2023 annual financial data
Sunshine Biopharma Inc. 2023 Operating margin
Sunshine Biopharma Inc. 2023 operating margin with verified reported values.
Direct answer
Operating margin was -19.86%.
Operating income was -4,785,299 USD and net income was -4,506,044 USD.
Operating cash flow was -8,775,111 USD.
Get free Sunshine Biopharma Inc. email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Revenue
- 24,092,787 USD
- Operating income
- -4,785,299 USD
- Net income
- -4,506,044 USD
- Operating cash flow
- -8,775,111 USD